Idiopathic Portal Vein Thrombosis: Endovascular Intervention Leads the Way to Recanalization
Background Data on treating idiopathic portal vein thrombosis (IPVT)—via anticoagulation (AC), systemic thrombolysis (ST), endovascular intervention (EVI), and surgery—are limited, despite the potentially severe clinical implications of this condition. This study aims to compare treatment outcomes a...
Saved in:
| Main Authors: | Xiaolu Zhu MS, Zhize Peng MS, Yinjun Xu MS, Yuanqiang Lu PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296251368885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endovascular intervention for portal vein system thrombosis in a patient with protein S deficiency: A case report
by: Min Jeong Choi, et al.
Published: (2025-04-01) -
Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
by: Xiulin Xiao M.S., et al.
Published: (2024-11-01) -
Risk Factors and Management of Portal Vein Thrombosis after Hepatectomy: A Single-Center Experience
by: Kazuki Wakizaka, MD, PhD, et al.
Published: (2024-12-01) -
Portal vein thrombosis in COVID-19 infection
by: Stefanie Sinz, et al.
Published: (2021-04-01) -
Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)